MY ACCOUNT | NEWSLETTER |

University Products notes upcoming guidance to impact OTC antibiotics


Vaccine company, University Products LLC, has highlighted upcoming implementation of FDA Guidance 263 which calls for OTC antibiotics to be used with veterinary consultation. Oversight by a veterinarian will disallow cattle producers from purchasing these antibiotics on their own in order to address antibiotic resistance, according to University Products.

University Products has shared that the pending change has led cattle companies to change their approach to vaccinations in order to head off common herd diseases such as anaplasmosis, which would previously have been treated with antibiotics. 

"We are getting calls every day from doctors that are changing to vaccine strategies and away from OTC to fight anaplasmosis," said Gene Luther, DVM, PhD "They are realizing that the vaccine is the best protection, at the best price."

University Products offers an USDA-approved vaccine against anaplasmosis, a disease which is estimated to cause losses as high as $14 to $19 billion each year, according to the company. The two-dose vaccine does not prevent infection but lessens severity of disease.   

"Our vaccine is a purified antigen of the organism that is actually causing the problem in cattle: A. marginale," Dr. Luther explained. "Rather than fighting infection after it happens with antibiotics, our vaccine keeps the organism from causing life-threatening symptoms in the first place. It is important to vaccinate against this specific organism and keep up with yearly booster shots. Your cows can continue to be a carrier of the disease – acting as reservoirs of infected blood for both insects and needles year after year. The only safe herd is a fully vaccinated herd."


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top